|
Reports
of recent clinical trial data
Contributors
were selected by Barry Bultz, PhD, RPsych; Hagen Kennecke,
MD, MPH, FRCPC; Joseph Ragaz, MD, FRCPC; and Neil Reaume,
BSc, MD, FRCPC, MSc.
|
To view the clinical trial data of the following topics click
here (pdf format)
Supportive
care
Symptom patterns in patients with advanced
cancer
Margaret Fitch, MScN, PhD,
Head Oncology Nursing; Co-Director Patient and Family Support Program,
Odette Cancer Centre; Associate Scientist, Sunnybrook Health Sciences
Centre; and Barry D. Bultz, PhD, RPsych, Director, Department of
Psychosocial Oncology: Supportive, Pain and Palliative Care, Tom
Baker Cancer Centre; Adjunct Professor, Department of Oncology,
Faculty of Medicine, University of Calgary
STUDY SUMMARY: Age and gender differences
Colon
cancer
Biochemical markers
Hagen Kennecke, MD, MPH, FRCPC, Medical
Oncologist, British Columbia Cancer Agency
STUDY SUMMARY: Predictive value of MSI status
in Stage II and II colon cancer
STUDY SUMMARY: Stage specificity of molecular markers
Breast
cancer
Nab-paclitaxel in metastatic disease
Susan Dent, MD, BSc, FRCPC, Ottawa
Hospital Regional Cancer Centre, Associate Professor of Medicine,
University of Ottawa
TRIAL SUMMARY: Bevacizumab with three dosages of nab-paclitaxel
Renal
cancer
Advanced disease
Bernhard Eigl, MD, FRCPC, Medical
Oncologist, Tom Baker Cancer Centre; Southern Alberta Cancer Research
Institute, Calgary, AB
TRIAL SUMMARY : Pazopanib vs placebo
To view the clinical trial data click
here (pdf format)
|
